# DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer

> **NCT00899548** · — · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 182 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **GENETIC:** DNA methylation analysis
- **GENETIC:** microarray analysis
- **GENETIC:** polymerase chain reaction
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00899548
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2010-06
- **Final completion:** 2016-10
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2019-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00899548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00899548, "DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00899548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*